Chalkis Health Industry Co., Ltd

Symbol: 000972.SZ

SHZ

3.04

CNY

Market price today

  • 24.0882

    P/E Ratio

  • 0.4015

    PEG Ratio

  • 2.34B

    MRK Cap

  • 0.00%

    DIV Yield

Chalkis Health Industry Co., Ltd (000972-SZ) Financial Statements

On the chart you can see the default numbers in dynamics for Chalkis Health Industry Co., Ltd (000972.SZ). Companys revenue shows the average of 822.366 M which is 0.424 % gowth. The average gross profit for the whole period is 126.18 M which is 0.900 %. The average gross profit ratio is 0.123 %. The net income growth for the company last year performance is 3.149 % which equals -3.911 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Chalkis Health Industry Co., Ltd, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.483. In the realm of current assets, 000972.SZ clocks in at 781.87 in the reporting currency. A significant portion of these assets, precisely 110.646, is held in cash and short-term investments. This segment shows a change of -0.467% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 3.888, if any, in the reporting currency. This indicates a difference of 388752800.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 72.117 in the reporting currency. This figure signifies a year_over_year change of 32.989%. Shareholder value, as depicted by the total shareholder equity, is valued at 203.542 in the reporting currency. The year over year change in this aspect is 1.135%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 50.561, with an inventory valuation of 616.39, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 15.7. Account payables and short-term debt are 104.12 and 346.46, respectively. The total debt is 418.96, with a net debt of 308.31. Other current liabilities amount to 374.52, adding to the total liabilities of 997.72. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

balance-sheet.row.cash-and-short-term-investments

694110.6207.520.5
37
80.6
56.6
123.7
223
335
126.8
317.1
532.8
512.8
673.8
413.1
1014.3
434.6
389.3
257.4
107.3
110.8
82.6
167.7
121.8
76.1
20.4
6.6

balance-sheet.row.short-term-investments

-0.24000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

264.5850.6107.7163.9
183.4
223.2
312.1
160
225.7
266.6
504.7
403.1
637.4
778.4
1098.4
1267.6
1277.1
861.4
896.5
806.9
476.3
458.7
296.6
386.2
66.4
25.2
26
14.3

balance-sheet.row.inventory

1950.35616.4216.8160.8
0
26.1
242.5
902.1
641.3
587.4
419
391.6
733.3
1184
1482.5
1363.8
1141.3
1188.3
998.4
680.2
412.8
190.6
210.2
167.1
180.4
92.8
79.6
57.6

balance-sheet.row.other-current-assets

71.624.33.913.3
7
6.4
7.8
89
90.1
95
-188.8
-112.1
-171.4
-174.5
-265.2
-66.4
-146.5
0.6
0.6
0.1
0
1.5
2.5
1.2
291.2
198.5
161.8
55.1

balance-sheet.row.total-current-assets

2980.54781.9535.8358.6
221.3
336.3
619
1274.9
1180.1
1284
861.8
999.8
1732.2
2300.7
2989.5
2978.2
3286.1
2484.9
2284.8
1744.6
996.5
761.5
591.9
722.1
659.8
392.7
287.8
133.7

balance-sheet.row.property-plant-equipment-net

1513.99421.7286.8315.3
354.4
400.4
502.2
826.3
851.1
978.4
826.9
1563.4
1823.6
1964.9
2154.1
2189.9
1862.9
1939.3
1508.4
1313.6
1102.1
966.7
641.9
374.5
332.8
163.8
127.7
45.4

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
90.6
99.1
102
107.4
115.1
27.6
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

49.7415.71.92
2
2
84.5
92.9
97.1
101.5
13.1
104.7
121.5
127
139.4
145.9
155
143.4
38.1
29.5
5.6
5.2
11.9
15.5
18.8
20.9
20.7
1.8

balance-sheet.row.goodwill-and-intangible-assets

49.7415.71.92
2
2
84.5
92.9
97.1
101.5
13.1
104.7
121.5
127
229.9
245
257.1
250.8
153.2
57.1
5.6
5.2
11.9
15.5
18.8
20.9
20.7
1.8

balance-sheet.row.long-term-investments

15.953.900
0
402.4
0
0
0
0
0
0
0
0
0
0
0
0
243.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

3.590.80.80
0
1.5
1.2
2
1.5
0.8
0.5
1.3
1.9
1.9
65.3
2.8
4.8
4.8
0.6
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

68.780.10.10.2
4.8
-402.4
19.8
151.2
282.8
265
268.7
36.2
47
55.7
82.6
193.3
146
163.6
31.6
381.9
318.8
184.7
164.7
117
27.3
9.7
4.7
2.3

balance-sheet.row.total-non-current-assets

1652.05442.2289.5317.5
361.2
404
607.7
1072.3
1232.5
1345.8
1109.2
1705.7
1994
2149.5
2532
2631
2270.7
2358.4
1937.1
1752.5
1426.6
1156.6
818.4
507
378.9
194.3
153.2
49.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

4632.591224.1825.4676
582.5
740.3
1226.7
2347.2
2412.6
2629.8
1971
2705.4
3726.2
4450.2
5521.5
5609.2
5556.8
4843.4
4221.9
3497.1
2423.1
1918.1
1410.4
1229.1
1038.8
587
441
183.1

balance-sheet.row.account-payables

413.66104.188.140.3
32.5
28
60.8
329.7
631.7
720.2
517.1
155.4
249.5
876.3
473.5
633.9
533.5
707.5
688.7
410.4
486.8
358.9
176.4
79.4
64.2
36
18
1.6

balance-sheet.row.short-term-debt

1111.59346.512.318.4
0.4
33.3
198.4
344.1
350.8
370.8
305.6
676.6
806.8
1870
2633.9
2144.6
2417.9
1798.6
1537.5
1496.1
658.1
390.2
395.5
365
399.4
213.6
163.1
130.2

balance-sheet.row.tax-payables

8.550.317.32
2.2
3.5
9.2
8.9
2.4
1.2
-72.5
1.7
-48.2
-215.5
-102.2
-176.1
-61.4
-23.8
-7.9
-10.6
12.9
-32.2
-15.4
3.7
3.6
18.5
6.3
-1.2

balance-sheet.row.long-term-debt-total

304.1272.100
20
0
0
0
0
0
62.5
133
50.1
417.5
809.9
936.6
480.6
520.8
392.2
360.7
510.7
529.9
252.8
229.2
25
35
15
15

Deferred Revenue Non Current

72.2616.92.42.7
3.1
3.4
8.8
5.3
5.4
5.5
5.6
7.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

725.3374.5449409.7
0.8
6.2
141.5
52.1
57
26.9
5
19.9
39.4
14.9
13.9
56.8
38.4
109.1
26.4
11.5
6.2
29.7
19.2
17.6
21.7
1
2.3
1.3

balance-sheet.row.total-non-current-liabilities

526.1872.5128.1133.3
155.6
3.9
14.1
18.6
47
63.6
126.4
161.7
66.3
592.7
1000.8
1154.8
736.5
520.8
394.2
361.7
513
541
267.1
253.4
32.2
35.4
18
18

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0.770.400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

3908.44997.7724.9601.7
401.3
292.3
783.8
1466.5
1652.4
1599.4
1203.5
2960.3
3508.5
4378.3
4134.3
4409.7
3995.6
3513.9
2948.9
2626.6
1795
1339.8
913.9
773
613.4
406.1
278.9
154.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3085.13771.3771.3771.3
771.3
771.3
771.3
771.3
771.3
771.3
771.3
771.3
771.3
482.1
482.1
419.1
419.1
322.4
179.1
124.6
124.6
124.6
124.6
124.6
124.6
79.6
79.6
12

balance-sheet.row.retained-earnings

-6832.68-1675.8-1784.1-1810.1
-1703.3
-1437.4
-1493.3
-1069.5
-1101.8
-847.7
-785.7
-1698.2
-1332.5
-1396.5
-244.9
-15.3
-43.1
8.8
16.6
111.4
91.6
71.5
14.9
0.5
4.7
0
-5.9
2.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

3351.9567.9567.9567.9
567.9
566.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

1080.39540.2540.2540.2
540.2
541.7
1160.5
1176.2
1162.4
1163.9
841.3
972.7
975.2
1123.8
1122.8
628
568.3
672.9
756
394
338.3
314.1
287.2
276.9
269.2
90.4
85.2
8.3

balance-sheet.row.total-stockholders-equity

684.74203.595.369.2
176
441.9
438.5
878
831.8
1087.4
826.9
45.8
414
209.3
1360
1031.8
944.3
1004
951.7
629.9
554.5
510.2
426.8
402
398.5
170
158.9
22.4

balance-sheet.row.total-liabilities-and-stockholders-equity

4632.591224.1825.4676
582.5
740.3
1226.7
2347.2
2412.6
2629.8
1971
2705.4
3726.2
4450.2
5521.5
5609.2
5556.8
4843.4
4221.9
3497.1
2423.1
1918.1
1410.4
1229.1
1038.8
587
441
183.1

balance-sheet.row.minority-interest

22.525.95.15.1
5.2
6
4.4
2.7
-71.6
-57
-59.3
-300.7
-196.4
-137.5
27.2
167.7
616.9
325.4
321.3
240.6
73.6
68.2
69.7
54.1
26.9
11
3.2
6.5

balance-sheet.row.total-equity

707.25209.5100.474.3
181.2
447.9
442.9
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

4632.59---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

15.713.900
0
402.4
0
51.7
179
174.8
174.9
29.4
36
43.1
81.6
192.7
145.4
162.6
257.7
370.4
307.3
176
154.4
108.7
10.3
0
0
0

balance-sheet.row.total-debt

1416.4841912.318.4
20.4
33.3
198.4
344.1
350.8
370.8
368
809.6
856.9
2287.5
3443.8
3081.2
2898.5
2319.4
1929.7
1856.8
1168.8
920.1
648.3
594.2
424.4
248.6
178.1
145.1

balance-sheet.row.net-debt

722.48308.3-195.1-2.1
-16.6
-47.3
141.8
220.3
127.8
35.9
241.2
492.4
324.1
1774.7
2770
2668.1
1884.2
1884.8
1554.8
1599.4
1061.5
809.3
565.6
426.5
302.5
172.5
157.7
138.6

Cash Flow Statement

The financial landscape of Chalkis Health Industry Co., Ltd has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -3.172. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 21.21 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -216703917.000 in the reporting currency. This is a shift of 20.941 from the previous year. In the same period, the company recorded 41.05, 0, and -536.29, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -16.47 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 875.01, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

97.34108.226.1-106.9
-266.7
5.1
-462.8
100.2
-268.7
-59.2
108.2
-468.8
5.9
-1317.2
-352.9
14.7
-70.7
58.9
-50.4
59.7
58.5
88.2
43.4
19
27.5
26.9

cash-flows.row.depreciation-and-amortization

-1.6441.144.845.6
47
53.1
90.9
96.4
109.1
100.1
97.2
172.9
178.7
187.3
186.4
177.4
151.4
153.1
124.6
88.7
63.7
47.3
28.6
23.2
12.2
9.2

cash-flows.row.deferred-income-tax

00-0.80
1.5
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-427.70.80
-1.5
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-348.34-327.154.8-200.2
134.9
134.1
642.4
-469.8
-158.1
-168.6
-549.8
346.9
-673
-778.5
-168.1
-1012.5
-244.5
-216
-332.7
-482.3
-146.2
102
-59.2
-96
-212.8
-30.2

cash-flows.row.account-receivables

33.0733.119.8-16.2
-23.3
-55.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-399.84-399.8-55.9-177
0.1
216.1
641.4
-287.9
-84.6
-185.9
-177.5
-51.1
709.1
-62.9
-381.2
-222.5
47.1
-189.9
-321.9
-267.3
-222.3
19.7
-43.1
2.6
-87.3
-14.1

cash-flows.row.account-payables

021.291.6-7
156.6
-26.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

18.4318.4-0.80
1.5
-0.4
1
-181.9
-73.5
17.3
-372.3
398
-1382.1
-715.6
213.1
-790
-291.6
-26.1
-10.8
-215
76.1
82.4
-16.1
-98.6
-125.5
-16.2

cash-flows.row.other-non-cash-items

22.15423.37272.8
75
-49.6
145.8
97
110.7
89.3
188.3
294.4
460.1
1002.7
-93.7
148.9
308.6
227.8
323.5
504.4
66.8
31.7
-7.4
18.1
13.6
27.3

cash-flows.row.net-cash-provided-by-operating-activities

-230.49000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-222.48-216.6-14.1-12
-3.9
-0.6
-8.6
-14.7
-14.9
-302.4
-36.9
-8.9
-13.3
-84.8
-153.7
-431.6
-113.3
-162.5
-158.8
-96.7
-184.3
-423.4
-176.2
-83.1
-205.3
-39.3

cash-flows.row.acquisitions-net

3.822.91.21.2
0
39.9
25.2
0
0
-0.8
0
0
0
0
4.2
0.3
3.1
-126.6
0.3
0.1
2.5
0.1
0
91.2
206.1
0

cash-flows.row.purchases-of-investments

-2.01-4-1.2-1.2
0
0
0
0
-6.1
0
0
0
0
0
-5
-19.4
-14.8
-21.5
-10
-82.2
-77.5
-14.3
-22
-61.4
-8
0

cash-flows.row.sales-maturities-of-investments

1132
0
0
0
4.7
0
0
0
0
0
0
564
22.1
6.9
39.3
0.8
0.8
20.6
11.9
47.1
0.5
2
0

cash-flows.row.other-investing-activites

2.0101.21.2
0
94.6
1.6
6.6
0
1
0
3.4
-2
11.1
-1.1
-9.7
47.9
68.1
8.3
26.5
12.4
-49.5
-1.8
-83.1
-205.3
1.2

cash-flows.row.net-cash-used-for-investing-activites

-217.66-216.7-9.9-8.8
-3.9
133.9
18.1
-3.4
-21
-302.2
-36.9
-5.5
-15.3
-73.7
408.3
-438.4
-70.1
-203.3
-159.3
-151.4
-226.4
-475.1
-153
-135.8
-210.6
-38.1

cash-flows.row.debt-repayment

-315.52-536.3-18-2
-32.9
-165.1
-235
-355.8
-287
-472.3
-520.3
-913.7
-1426.4
-3717.9
-3447
-2160.1
-1711.6
-2000
-2059.4
-1254.1
-615.4
-751.3
-606.7
-650.4
-370.1
-147.1

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-23.9-16.5-12.9-3.9
-0.2
-9.4
-32.9
-31.9
-24.9
-33.5
-37.9
-54.6
-107.7
-163.4
-174.4
-173.8
-187
-166.3
-118.8
-105.2
-74.8
-58.5
-42
-30.6
-33.4
-17.4

cash-flows.row.other-financing-activites

447.32875-1.8186.8
5
-56
-255.6
497.2
419.2
1051.9
568.7
471.3
1687.2
4568
3903.7
2843.4
2412.2
2191
2403.3
1481.7
864.1
1043.8
711.4
898.7
819.3
225.3

cash-flows.row.net-cash-used-provided-by-financing-activities

260.27322.2-32.7180.9
-28.2
-230.4
-523.5
109.5
107.3
546.1
10.5
-497.1
153.1
686.7
282.3
509.5
513.6
24.7
225.1
122.5
173.9
234
62.7
217.8
415.8
60.7

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0.1
1.6
0.1
3.2
0.9
-7.4
-1.8
-8
-8.2
-0.8
-8.5
0
1
-1
6.2
0
-0.1
-0.1
0
0

cash-flows.row.net-change-in-cash

-210.01-96.8155.2-16.6
-42
46.2
-89
-68.9
-120.5
208.6
-181.5
-164.7
107.7
-300.8
254.1
-601.1
579.6
45.3
131.9
140.5
-3.5
28.2
-85.1
46
45.7
55.7

cash-flows.row.cash-at-end-of-period

691.9110.6175.620.4
37
79
32.8
121.8
190.3
310.8
102.2
309.5
474.1
366.4
667.3
413.1
1014.3
434.6
389.3
247.8
107.3
110.8
82.6
167.7
121.8
76.1

cash-flows.row.cash-at-beginning-of-period

901.91207.520.437
79
32.8
121.8
190.7
310.8
102.2
283.7
474.1
366.4
667.3
413.1
1014.3
434.6
389.3
257.4
107.3
110.8
82.6
167.7
121.7
76.1
20.4

cash-flows.row.operating-cash-flow

-230.49-182.2197.7-188.7
-9.9
142.7
416.3
-176.2
-206.9
-38.4
-156.1
345.3
-28.3
-905.8
-428.3
-671.5
144.7
223.9
65
170.5
42.9
269.2
5.3
-35.8
-159.5
33.1

cash-flows.row.capital-expenditure

-222.48-216.6-14.1-12
-3.9
-0.6
-8.6
-14.7
-14.9
-302.4
-36.9
-8.9
-13.3
-84.8
-153.7
-431.6
-113.3
-162.5
-158.8
-96.7
-184.3
-423.4
-176.2
-83.1
-205.3
-39.3

cash-flows.row.free-cash-flow

-452.97-398.8183.7-200.7
-13.8
142
407.7
-190.9
-221.8
-340.8
-192.9
336.4
-41.6
-990.6
-582
-1103.1
31.5
61.4
-93.7
73.8
-141.4
-154.2
-171
-118.8
-364.8
-6.2

Income Statement Row

Chalkis Health Industry Co., Ltd's revenue saw a change of -0.034% compared with the previous period. The gross profit of 000972.SZ is reported to be 133.27. The company's operating expenses are 67.88, showing a change of 88.030% from the last year. The expenses for depreciation and amortization are 41.05, which is a -0.083% change from the last accounting period. Operating expenses are reported to be 67.88, which shows a 88.030% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.465% year-over-year growth. The operating income is 65.38, which shows a -0.465% change when compared to the previous year. The change in the net income is 3.149%. The net income for the last year was 108.24.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

income-statement-row.row.total-revenue

542.32569.5589.3174.5
23
213.2
626.7
517.7
588.2
682.9
416.8
954.9
1246
1424.8
1512
1660
1967.5
2142.8
1532.7
1030.3
695.7
948.8
676.8
549.3
467.6
392.2
361
239.9

income-statement-row.row.cost-of-revenue

409.89436.2434.5164.5
36.5
200.3
738.6
464
538.2
619.8
365.2
846.2
1020.1
1396.8
1636.9
1306.4
1477
1738.4
1275.4
773.8
460.7
729.2
517.7
438.8
389.8
300.9
290.4
200.7

income-statement-row.row.gross-profit

132.43133.3154.89.9
-13.5
12.9
-111.9
53.7
49.9
63.1
51.6
108.7
225.9
28
-125
353.7
490.5
404.3
257.3
256.5
235
219.7
159.1
110.5
77.8
91.3
70.5
39.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

1.18---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

14.32---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

11.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-0.31024.127.4
27.2
60.1
140.8
235.7
6.1
117.2
345.4
14
642.3
16.9
0.2
60.9
8.5
41.6
13.5
13.9
7.7
17.5
18.2
22.8
15
12.7
7.3
14.1

income-statement-row.row.operating-expenses

68.8867.936.142.9
39.5
68.8
182.6
114.4
181.4
149.1
98.4
321.5
339.1
255.6
261.2
212.3
227.4
175.1
144.9
102.9
127.8
124
115.2
95.5
48.2
48.9
36.2
29.6

income-statement-row.row.cost-and-expenses

478.77504.1470.6207.4
76
269.1
921.2
578.4
719.6
768.9
463.5
1167.7
1359.2
1652.4
1898.1
1518.7
1704.4
1913.5
1420.3
876.7
588.5
853.1
632.8
534.3
438
349.7
326.6
230.3

income-statement-row.row.interest-income

-0.841.90.80.1
0.1
0.1
0.4
0.9
1
2.2
1.3
5.7
5.9
10
5.5
0
9.7
6.9
4.9
2.5
1.5
1.1
1.2
2.7
2.3
0
0
0

income-statement-row.row.interest-expense

24.5922.115.910.3
4.4
12.5
37.3
34
30.2
31.5
32.5
69.3
240.3
206.6
181
168.3
212.6
164.8
114.1
100.2
77.6
41.3
30.8
26.3
14.8
17.7
15.9
16.2

income-statement-row.row.selling-and-marketing-expenses

11.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

49.7744-90.9-68
-136.7
42
-2.3
158.8
-137.6
26.9
155.6
-254.9
187.7
-1024.7
45.7
-124.8
-307.6
-166.7
-160.5
-108.4
-57.7
-23
-10.4
-10.5
-5.9
-11.7
-16.2
-3.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-0.31024.127.4
27.2
60.1
140.8
235.7
6.1
117.2
345.4
14
642.3
16.9
0.2
60.9
8.5
41.6
13.5
13.9
7.7
17.5
18.2
22.8
15
12.7
7.3
14.1

income-statement-row.row.total-operating-expenses

49.7744-90.9-68
-136.7
42
-2.3
158.8
-137.6
26.9
155.6
-254.9
187.7
-1024.7
45.7
-124.8
-307.6
-166.7
-160.5
-108.4
-57.7
-23
-10.4
-10.5
-5.9
-11.7
-16.2
-3.7

income-statement-row.row.interest-expense

24.5922.115.910.3
4.4
12.5
37.3
34
30.2
31.5
32.5
69.3
240.3
206.6
181
168.3
212.6
164.8
114.1
100.2
77.6
41.3
30.8
26.3
14.8
17.7
15.9
16.2

income-statement-row.row.depreciation-and-amortization

29.6741.144.845.6
-16.6
53.1
377.8
21
109.1
100.1
97.2
172.9
178.7
187.3
186.4
177.4
151.4
153.1
124.6
88.7
63.7
47.3
28.6
23.2
12.2
9.2
12.3
14.7

income-statement-row.row.ebitda-caps

78.62---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

48.9665.4122.3-38.9
-128.5
-35.5
-459.9
-137.6
-275.1
-176.2
-236.6
-481.6
-567.3
-1269.2
-336
-9.9
-52.9
20.9
-61.5
59.7
59
85.7
40.9
14.8
25.7
29.5
22.3
-5.1

income-statement-row.row.income-before-tax

98.72109.431.4-106.9
-265.2
6.5
-462.2
98.1
-269
-59.1
108.8
-467.7
74.4
-1252.4
-340.5
16.6
-44.4
62.6
-48.1
59.4
58.1
88
46.3
21
32.2
36.5
23.9
7.5

income-statement-row.row.income-tax-expense

0.250.25.30
1.5
1.5
0.6
7.9
-0.4
0.1
0.6
1.1
68.5
64.8
12.4
1.9
26.3
3.6
2.3
1.3
0.3
-0.2
3
2
4.7
9.6
2.1
4

income-statement-row.row.net-income

97.34108.226.1-106.9
-266.7
5
-462.8
26.6
-254.1
-48.3
11.3
-365.7
64
-1151.6
-215.1
27.8
-42.2
56
-65.6
48.7
53.3
82
37.6
19.8
27.1
25.4
22.3
4.8

Frequently Asked Question

What is Chalkis Health Industry Co., Ltd (000972.SZ) total assets?

Chalkis Health Industry Co., Ltd (000972.SZ) total assets is 1224071923.000.

What is enterprise annual revenue?

The annual revenue is 349243428.000.

What is firm profit margin?

Firm profit margin is 0.244.

What is company free cash flow?

The free cash flow is -0.587.

What is enterprise net profit margin?

The net profit margin is 0.179.

What is firm total revenue?

The total revenue is 0.090.

What is Chalkis Health Industry Co., Ltd (000972.SZ) net profit (net income)?

The net profit (net income) is 108237777.000.

What is firm total debt?

The total debt is 418960614.000.

What is operating expences number?

The operating expences are 67884311.000.

What is company cash figure?

Enretprise cash is 39545019.000.